PROVIDER PROFILE · NPI 1861809261

Elaine FerreiraFNP

PRACTICEALBERTO SOBRADOSee all providers at this practice →

Nurse PractitionerNorth Andover, MAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

624

Unique beneficiaries

—

Total services

774

Distinct HCPCS

Medicare payment

$49K

Peer benchmark

Total Medicare services vs. 5,906 Nurse Practitioner providers in MA — top quintile (cohort median 289).

PRESCRIBING · PART D · 2024

Total Rx claims

1,984

Beneficiaries

—

Total drug cost

$72K

Distinct drugs

Brand share

12.4%

Top prescribed drugs

Atorvastatin Calcium159 claims

Lisinopril150 claims

Sertraline Hcl97 claims

Levothyroxine Sodium90 claims

Omeprazole90 claims

QUALITY · MIPS · 2024

Final MIPS score

92.0

Quality

76.6

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.71%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$58

Payment records

By payment type

Food and Beverage$58

REFERRAL NETWORK

Where Elaine Ferreira's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Quest Diagnostics Massachusetts Llc Clinical Laboratory · Marlborough, MA	74	241
SOBRADO, ALBERTO	54	191
NORTHEAST HOSPITAL CORPORATION	27	96
STEWARD HOLY FAMILY HOSPITAL, INC.	19	73
Stewart Hou Diagnostic Radiology · Lawrence, MA	12	24

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history